AU Optronics Corp (AUO, 友達光電) is planning to build an advanced flat-panel plant in Taichung, aiming for commercial production by 2025, the Hsinchu-based company said on Friday, as it reported a record net profit for last year, driven by strong global demand.
AUO chief financial officer Benjamin Tseng (曾煜智) told an investors’ conference that the company’s board had approved increasing its capital expenditure budget by NT$28 billion (US$1.01 billion) this year, part of which would be allocated to the construction of the new plant.
AUO expects an overall capital expenditure of NT$45 billion this year, Tseng said.
Photo: Chen Mei-ying, Taipei Times
AUO chairman Paul Peng (彭双浪) said the company would spend more next year to install the plant’s equipment and prepare for its commercial operations by 2025.
The new plant would be in the Central Taiwan Science Park (中部科學園區) in Taichung’s Houli District (后里), Peng said.
AUO president and chief operating officer Frank Ko (柯富仁) said the plant would be a smart production site for advanced 8.5th and perhaps 8.6th-generation flat screens, as part of AUO’s efforts to set up micro-LED display production.
The company is weighing whether to use amorphous silicon technology or low-temperature polysilicon technology on the plant’s production lines, Ko said.
AUO reported a record NT$61.33 billion in net profit for last year, up 1,716.5 percent from a year earlier, with earnings per share of NT$6.44, compared with NT$0.36 in 2020.
Its consolidated sales rose 36.8 percent year-on-year to NT$370.69 billion last year, the company said.
AUO said it benefited from a booming global stay-at-home economy in the first half of last year, amid the COVID-19 pandemic.
In the second half, when many countries eased movement restrictions, business activity increased, driving demand for products in the business sector, it added.
Gross margin grew to 24.5 percent, compared with 8.4 percent in 2020, AUO said.
Screen shipments rose 0.6 percent from a year earlier to 25.72 million square meters last year, the company said.
Peng said shipments of large screens dropped sharply in the second half of last year, but the decline has been showing signs of moderating, while inventory levels have reached healthy levels.
So far this year, inflationary pressure has pushed up raw material prices, creating uncertainty in the flat-panel industry, he said.
With the global electric vehicle market gaining momentum, business opportunities are growing in the industry, which might offset the weakness of the TV panel market, Peng said.
This time was supposed to be different. The memorychip sector, famous for its boom-and-bust cycles, had changed its ways. A combination of more disciplined management and new markets for its products — including 5G technology and cloud services — would ensure that companies delivered more predictable earnings. Yet, less than a year after memory companies made such pronouncements, the US$160 billion industry is suffering one of its worst routs ever. There is a glut of the chips sitting in warehouses, customers are cutting orders and product prices have plunged. “The chip industry thought that suppliers were going to have better control,” said
Enimmune Corp (安特羅生技) has obtained marketing approval from the Food and Drug Administration (FDA) for its EnVAX-A71 vaccine for enterovirus 71 (EV-71), becoming the nation’s first enterovirus vaccine completely made in Taiwan, it said yesterday. After spending 13 years and NT$1.5 billion (US$49.77 million) on the research and development of the vaccine, Enimmune plans to start manufacturing and marketing it by the end of March, the company said in a statement, without disclosing customer order figures. “It is possible that the vaccine would not be included in a national vaccination program initially, and consumers would need to pay for it themselves,” parent
Vaccine skeptics blocking transfusions for life-saving surgeries, Facebook groups inciting violence against doctors and a global search for unvaccinated donors — COVID-19 misinformation has bred a so-called “pure blood” movement. The movement spins anti-vaccine narratives focused on unfounded claims that receiving blood from people inoculated against COVID-19 “contaminates” the body. Some have advocated for blood banks that draw from “pure” unvaccinated people, while medics in North America say they have fielded requests from people demanding transfusions from donors who have not received a vaccine. In closed social media groups, vaccine skeptics — who brand themselves as “pure bloods” — promote violence against doctors
Asteroid mining start-up AstroForge Inc is planning to launch its first two missions to space this year as it seeks to extract and refine metals from deep space. The first launch, scheduled for April, is to test AstroForge’s technique for refining platinum from a sample of asteroid-like material. The second, planned for October, would scout for an asteroid near Earth to mine. The missions are part of AstroForge’s goal of refining platinum-group metals from asteroids, with the aim of bringing down the cost of mining these metals. It also hopes to reduce the massive amount of carbon emissions that stem from mining